The KPM Group DC LLC

The KPM Group DC LLC filed a Q2 report for Soleno Therapeutics, Inc. on July 19, 2026, reporting no lobbying activity.

Lobbying for Soleno Therapeutics, Inc. · Soleno is focused on development of novel therapeutics for treatment of rare diseases.

As filed: THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.

All filings by The KPM Group DC LLC · Everything Soleno Therapeutics, Inc. has reported

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Jul 28, 2026.

Filing · LD-2 quarterly report Q2 reportNo activity

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 19, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbying activity 0

No itemized activity in this filing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.